Journal article

The impact of HLA class I and EBV latency-II antigen-specific CD8( ) T cells on the pathogenesis of EBV Hodgkin lymphoma

K Jones, L Wockner, RM Brennan, C Keane, PK Chattopadhyay, M Roederer, DA Price, DK Cole, B Hassan, K Beck, D Gottlieb, DS Ritchie, JF Seymour, F Vari, P Crooks, SR Burrows, MK Gandhi

Clinical and Experimental Immunology | WILEY | Published : 2016

Grants

Awarded by Wellcome Trust


Awarded by NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES


Funding Acknowledgements

This study was conducted under the auspices of the Australasian Leukaemia and Lymphoma Group. K. J. and C. K. were supported by the Leukaemia Foundation (Australia). M. K. G. is supported by the Leukaemia Foundation of Queensland. D. A. P. is a Wellcome Trust Senior Investigator. S. R. B is an NHMRC Principal Research Fellow (APP1021452).